ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628906 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628906; 2) Community: the network communities that were significantly associated with the response to NSC 628906; 3) Molecule: the relationships between components within communities and NSC 628906; 4) MDR: the compounds that were significantly associated with the NSC 628906.

NSC Compound Enrichment Correlation
NSC 718370 Null 0.0348927754043159 -0.062154586
NSC 726365 Null 0.0348927754043159 0.076290843
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.0348927754043159 0.27782619
NSC 728133 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3,5-dichlorobenzene 0.0348927754043159 0.19497669
NSC 731129 2-[3,4,5(trimethoxy)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.0348927754043159 0.085473217
NSC 736624 Indenoisoquinoline derivative 0.0348927754043159 0.32645152
NSC 741296 Null 0.0348927754043159 0.22651261
NSC 748643 Mitaplatin 0.0348927754043159 0.34130244
NSC 749226 Abiraterone 0.0348927754043159 0.088049745
NSC 752270 2,7-Bis-[3-(2-chloro-benzylamino)-propyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate 0.0348927754043159 -0.054974068
Total:53  Current:37    [First] [Prev] [Next] [Last]